Clinical Scorecard: Cardiometabolic disorders vary by HIV status
At a Glance
| Category | Detail |
|---|---|
| Condition | Cardiometabolic disorders in young adults with HIV |
| Key Mechanisms | Differences in metabolic outcomes based on HIV status and exposure |
| Target Population | Young adults aged 18 to 24 years with and without HIV |
| Care Setting | Tertiary hospitals in Abuja, Nigeria |
Key Highlights
- Participants with perinatally acquired HIV had lower odds of prehypertension and elevated blood glucose.
- 65% of participants had low high-density lipoprotein cholesterol.
- 12% of participants had diabetes and 10% had metabolic syndrome.
- Male participants had higher odds of prehypertension and hypertension.
- 91% of participants with HIV were on a dolutegravir-based regimen.
Guideline-Based Recommendations
Diagnosis
- Hypertension classified using Seventh Joint National Committee criteria.
- Diabetes defined by random blood glucose, hemoglobin A1c, or treatment history.
Management
- Monitor metabolic outcomes in young adults with HIV.
Monitoring & Follow-up
- Regular assessment of blood pressure, glucose levels, and lipid profiles.
Risks
- Potential bias in diabetes diagnosis using hemoglobin A1c among people with HIV.
Patient & Prescribing Data
660 young adults aged 18 to 24 years, including those with perinatally and nonperinatally acquired HIV.
Median duration of antiretroviral therapy was 11.7 years, with 55% achieving HIV-1 RNA below 20 copies/mL.
Clinical Best Practices
- Utilize multivariable models to assess associations between characteristics and metabolic outcomes.
- Consider potential biases when diagnosing metabolic conditions in HIV populations.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
